Some anticytoplasmic protein monoclonal antibodies (MAbs) from mice immunized by infection with BruceUla ovis cells have been obtained. One of these MAbs, B124, was used to purify by immunoaffinity a protein with a pI of 5.6 and a molecular mass of 18 kDa. This protein was present in all of the rough and smooth BruceUla species studied, but it could not be detected in Yersinia enterocolitica 09. Three internal peptides of this protein were partially sequenced; no homology with other bacterial proteins was found. The immunogenicity of the 18-kDa protein was studied with both human and bovine sera by a capture enzyme-linked immunosorbent assay system with MAb B124.
The serological procedures currently used in the diagnosis of both human and bovine brucellosis are based on the detection of anti-lipopolysaccharide (LPS) antibodies. These antibodies remain high even after patients with brucellosis recover from the disease (17) , and moreover, they are unable to differentiate infected cattle from healthy vaccinated cattle (22) . On the other hand, tests performed with either LPS or LPS-rich extracts lead to extensive cross-reactions with other gram-negative bacteria (7) . Thus, it might be assumed that the determination of the humoral response against LPS-free proteins could help to avoid those undesirable reactivities.
Measuring the humoral immune response against cytoplasmic proteins was previously shown to be important for the diagnosis of human brucellosis (10) . A mixture of proteins depleted of LPS by immunoadsorption with an anti-LPS monoclonal antibody (MAb) was prepared. This antigen was used in an enzyme-linked immunosorbent assay (ELISA) to differentiate active infections from inactive infections (10) .
Our goal in the present study was to obtain a single protein component from the cytoplasmic fraction which behaves like LPS-free CYT with regard to its ability to detect only active brucellosis.
To this end, we have prepared anti-cytoplasmic protein MAbs according to the protocol of Cloeckaert et al. (6) using spleen cells from Brucella ovis-infected mice.
By using one of these MAbs (BI24), we could isolate and partially characterize a protein component specific to the Brucella genus and with a molecular mass of 18 kDa. Tsang et al. (18) . Ascitic fluid of MLAb BI24 was diluted 1/100.
MATERIALS AND METHODS

SDS
Preparation of cytoplasmic fraction. Suspension cultures of Brucella abortus 19S cells were killed by the addition of 0.4% formaldehyde. The cytoplasmic fraction (CYT) was obtained as described by Verstreate et al. (19) with minor modifications as previously described (10) . Briefly, bacterial cells were suspended in Tris buffer and broken by extrusion with an X-Press (type 25; AB BIOS) and then digested with DNase and RNase. Cell envelopes were harvested by centrifugation at 360,000 x g for 2 h. The resulting supernatant (CYT) was stored at -20°C.
Preparation of LPS-free CYT antigenic fraction. The LPSfree CYT antigenic fraction was prepared by immunoadsorption of the CYT fraction with the anti-LPS MAb BC68 coupled with CNBr-activated Sepharose 4B (Pharmacia) as previously described (10) .
Human sera. In this study, we analyzed the sera from outpatients in the Brucellosis Department of Hospital Muniiz who were classified into three different groups as follows.
(i) Patients with active brucellosis. This group included patients with compatible symptoms (chills, fever, asthenia, arthralgia, sweating, weight loss, lymphadenopathy, and hepatosplenomegaly, etc.). Standard tube and slide agglutination tests with these sera showed titers equal to or higher than 1/100, and sera had positive Rose Bengal tests, positive agglutination with 2-mercaptoethanol, and positive complement fixation, as described earlier (10 Figure 1A shows the SDS-PAGE profile of the antigen purified from the B. abortus cytoplasmic fraction by immunoadsorption with the MAb BI24. As can be seen, this antigen shows a major band of 18 kDa, a minor band of 36 kDa, and other components with greater molecular masses which cannot be dissociated by 2-mercaptoethanol reduction (Fig. 1A) .
The same bands are seen by immunoblotting analysis when CYT and LPS-free CYT are used. Nevertheless, the 36-kDa band is masked by the multiplicity of bands developed by MAb B124. (Fig. 1B, lanes 3 and 4) . The antigen recognized by BI24, electrophoretically separated by twodimensional gel electrophoresis and developed by immunoblotting with the same MAb, shows two spots corresponding to 18 and 36 kDa, both of which have pIs of 5.6 (Fig. 1C) .
On the other hand, the 18-kDa component is present in all Brucella species studied but could not be detected in Yersinia enterocolitica 09 (Fig. 2) .
Microsequencing of the 18-kDa antigen. The microsequencing technique described by Matsudaira (14) applied to the 18-kDa band of the BI24 antigen showed that the aminoterminal amino acid was blocked. The method of Aebersold et al. (1) was then used as follows: the 18-kDa band was digested in situ with trypsin, and the resulting peptides were J. CLIN. MICROBIOL. We have shown in a previous paper that Brucella cytoplasmic proteins depleted of LPS were useful for differentiating between active and inactive human brucellosis (10).
Our present objective was to analyze whether any individual protein component had the same antigenic properties as the LPS-free CYT extract.
All of the anti-Brucella MAbs described so far are directed against LPS (5, 11, 21) or membrane proteins (6, 15 This antigen, like the LPS-free CYT (10), clearly differentiates between active and inactive human infections when used in an ELISA. The risks of possible interference by LPS in a capture ELISA can be ruled out in our system, since the extract containing the B124 antigen had been previously depleted of LPS (10) .
Because of the great individual variabilities in the humoral immune response among patients, it was surprising to find one individual component whose properties closely resemble those of a heterogeneous protein mixture.
The use of the B124 antigen for the analysis of human sera demonstrates that this antigen behaves in different immunogenic manners with regard to patients with either active or inactive brucellosis. In fact, while the patients suffering from active infections show high IgG reactivities, those with inactive infections do not react against the BI24 antigen. These results agree with those previously reported by us using LPS-free CYT (10) .
In spite of the low number of animals studied, when cow sera were analyzed, only infected animals produced antibodies against the BI24 antigen. The vaccinated healthy animals studied did not show reactivity toward this antigen, while all of them showed anti-LPS antibodies, as determined by ELISA (results not shown). This result is in agreement with the report of Wright and Nielsen (22) .
All of the results mentioned above suggest a direct relationship between the bacterial virulence and the immunogenicity of the BI24 antigen.
The results presented here emphasize the importance of studying the humoral immune response against cytoplasmic proteins of Brucella spp., as already reported (10) . It is also shown that the use of MAbs is an appropriate strategy for the identification, characterization, and application of Brucella protein antigens for diagnostic purposes.
